Levothyroxine recalls

The FDA has published 145 recalls involving Levothyroxine since 2012. The latest was reported on 2 Sep 2026. Most were for potency & assay. Accord Healthcare has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls145since 2012

Last 12 months28reported

Class I1510% of total

Ongoing61latest 2 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 18 1 0Feb 2 0 4May 1 7 1Aug 0 1 0Nov 0 1 0Feb 0 1 0May 0 13 0Aug 12 0

Severity split

Class I 15 10%Class II 128 88%Class III 2 1%

Why levothyroxine is recalled

Companies

Accord Healthcare2618%
Ibsa Pharma1510%
Pfizer1410%
Aidapak Services1410%
Major Pharmaceuticals128%
King Legacy, a wholly owned subsidiary of Pfizer118%
Viatris118%
Acella Pharmaceuticals107%

Brands

By year

20262719%
20251712%
20241812%
20231812%
202186%
202053%
201864%
201711%
201611%
20141510%

Ongoing levothyroxine recalls

61 active

Reported	Class	Recall	Company	Reason	Where
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide

All levothyroxine recalls, newest first

145 total

Reported	Class	Recall	Company	Reason	Where
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
8 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
1 Apr 2026Drug	CLASS II	Levothyroxine Sodium Tablets USP 150 mcg recalled by Macleods Pharma UsaLevothyroxine Sodium	Macleods Pharma USA	Potency & Assay	Nationwide
21 Jan 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg recalled	Alvogen	Packaging Defects	Nationwide
15 Oct 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
20 Aug 2025Drug	CLASS II	Levoxyl (levothyroxine sodium tablets, USP), 50 mcg recalled by PfizerLevoxyl	Pfizer	Potency & Assay	NY
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide

Should you stop taking Levothyroxine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.